Compare UONEK & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UONEK | MDCX |
|---|---|---|
| Founded | 1980 | 2008 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Broadcasting | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.7M | 31.1M |
| IPO Year | N/A | N/A |
| Metric | UONEK | MDCX |
|---|---|---|
| Price | $7.58 | $1.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $23.50 |
| AVG Volume (30 Days) | 5.6K | ★ 406.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.40 | $0.92 |
| 52 Week High | $14.00 | $8.94 |
| Indicator | UONEK | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 63.71 | 50.57 |
| Support Level | $7.41 | $0.92 |
| Resistance Level | $8.18 | $1.16 |
| Average True Range (ATR) | 0.44 | 0.14 |
| MACD | -0.31 | 0.02 |
| Stochastic Oscillator | 11.53 | 70.44 |
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.